BIVI Insider Trading Activity and SEC Form 4 Filings
BIVI insider trading summary
Over the past 12 months, insiders at Biovie Inc. (BIVI) reported 4 open-market purchases worth $49K by 4 insiders and no sales on SEC Form 4. Net insider buying was $49K.
Latest BIVI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 28, 2026 | Joseph M Palumbo | Chief Medical Officer | Buy | $10K (4,843 @ $2.16) |
| Aug 28, 2026 | Joanne Wendy Kim | Chief Financial Officer | Buy | $5K (2,500 @ $2.18) |
| Aug 28, 2026 | Amy Suzon Chappell | Director | Buy | $2K (727 @ $2.16) |
| Aug 27, 2026 | Cuong V Do | President & CEO | Buy | $32K (15,210 @ $2.08) |
| Aug 7, 2025 | Cuong V Do | President & CEO | Buy | $0 (5,000 @ $0.00) |
| Mar 4, 2024 | Cuong V Do | President & CEO | Buy | $0 (10,000 @ $0.00) |
| Dec 1, 2023 | Steve Gorlin | Director | Sell | $128K (75,680 @ $1.69) |
| Nov 30, 2023 | Cuong V Do | President & CEO | Buy | $18K (10,000 @ $1.78) |
| Sep 5, 2023 | Steve Gorlin | Director | Sell | $26K (8,560 @ $3.05) |
| Aug 22, 2023 | Richard J Berman | Director | Sell | $38K (10,805 @ $3.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.